Cleared Special

K211567 - BiMobile Instruments (for BiMobile Dual Mobility System)

K211567 is an FDA 510(k) clearance for BiMobile Instruments (for BiMobile Dual..., manufactured by Waldemar Link GmbH & Co. KG. The device is a Class 2 Orthopedic device with product code LZO cleared through the Special 510(k) pathway after a 378-day FDA review.

K211567 · Waldemar Link GmbH & Co. KG · Orthopedic device
Download Printable Device Report (PDF) Official FDA 510(k) Summary (PDF)
Optimized for regulatory review, auditing and printing
Jun 2022
Decision
378d
Days
Class 2
Risk

K211567 is an FDA 510(k) clearance for the BiMobile Instruments (for BiMobile Dual Mobility System). Classified as Prosthesis, Hip, Semi-constrained, Metal/ceramic/polymer, Cemented Or Non-porous, Uncemented (product code LZO), Class II - Special Controls.

Submitted by Waldemar Link GmbH & Co. KG (Norderstedt, DE). The FDA issued a Cleared decision on June 3, 2022 after a review of 378 days - an unusually long review period, suggesting complex equivalence evaluation.

This device falls under the Orthopedic FDA review panel, regulated under 21 CFR 888.3353 - the FDA orthopedic device regulatory framework. As a Special 510(k), this submission covers a manufacturer modification to an existing cleared device rather than a new device introduction.

Device pattern: Iterative device modification. Elevated predicate reliance profile. This Special 510(k) clearance confirms that the manufacturer's modifications remained within the established regulatory envelope of the original cleared device.

FDA 510(k) Submission Details - K211567

510(k) Number K211567 FDA.gov
FDA Decision Cleared Substantially Equivalent - Traditional 510(k) (SESE)
Date Received May 21, 2021
Decision Date June 03, 2022
Days to Decision 378 days
Submission Type Special
Review Panel Orthopedic (OR)
Summary Summary PDF
Third-party Review No - reviewed directly by FDA
Combination Product No
PCCP Authorized No
Regulatory Context
Review time vs. panel average
256d slower than avg
Panel avg: 122d · This submission: 378d
Pathway characteristics
Modification to existing cleared device.

LZO Device Classification - Class 2, Special Controls

Product Code LZO Prosthesis, Hip, Semi-constrained, Metal/ceramic/polymer, Cemented Or Non-porous, Uncemented
Device Class Class 2 - Special Controls
CFR Regulation 21 CFR 888.3353
What this classification means

Class II devices require demonstration of substantial equivalence to a legally marketed predicate device. This pathway does not require clinical trials - it relies on engineering equivalence and performance data. Most Orthopedic devices follow this clearance model.

Regulatory Consultant

LinkBio Corp.
Stefani Fuchs

The regulatory consultant manages the 510(k) submission process on behalf of the applicant - coordinating technical documentation, predicate strategy and FDA communications. Identifying the consultant behind a submission is a key signal for competitive regulatory intelligence.

Regulatory Peers - LZO Prosthesis, Hip, Semi-constrained, Metal/ceramic/polymer, Cemented Or Non-porous, Uncemented

All 533
Devices cleared under the same product code (LZO) and FDA review panel - the closest regulatory comparables to K211567.
SP-CL Hip Stem and LCU Hip System
K213770 · Waldemar Link GmbH & Co. KG · Sep 2022
implaFit® hip stems
K210678 · Implantcast GmbH · Aug 2022
DM Converter - TiN coated
K211891 · Medacta International S.A. · Jul 2022
M-Vizion Monobloc
K212327 · Medacta International S.A. · May 2022
Amis K Long
K220405 · Medacta International S.A. · Apr 2022
MP Reconstruction System
K213675 · Waldemar Link GmbH & Co. KG · Apr 2022
K211567 · BiMobile Instruments (for BiMobile Dual Mobility System)
Download PDF FDA Summary Waldemar Link GmbH & …